α1-Adrenoreceptor antagonists bearing a quinazoline or a benzodioxane moiety

Pharmaceutica Acta Helvetiae

Volumn 74, Issue 2-3, 2000, Pages 181-190

  Melchiorre, C ^a   Angeli, P ^b   Bolognesi, M L ^a   Chiarini, A ^a   Giardina D ^b   Gulini, U ^b   Leonardi, A ^c   Marucci, G ^b   Minarini, A ^a   Pigini, M ^b   Quaglia, W ^b   Rosini, M ^a   Tumiatti, V ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

^c Pharmaceutical R and D Division   (Italy)

Author keywords

1 Adrenoreceptor antagonists; Benzodioxane moiety; BMY 7378; Cystazosin; Prazosin; Quinazoline; WB 4101

Indexed keywords

2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 CARBAMOYLTRYPTAMINE; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1 ADRENERGIC RECEPTOR; BENZODIOXAN DERIVATIVE; CYCLAZOCINE; CYSTAZOSIN; PRAZOSIN; QUINAZOLINE DERIVATIVE; RECEPTOR SUBTYPE; SEROTONIN; SPIPERONE; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DRUG DESIGN; DRUG RECEPTOR BINDING; ENANTIOMER; HUMAN; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; DIOXANES; HUMANS; PRAZOSIN; QUINAZOLINES; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 17444451878     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-6865(99)00049-7     Document Type: Conference Paper

References (38)

1. Andrisano V., Marucci G., Melchiorre C., Tumiatti V. Stereoselectivity at α-adrenoreceptor subtypes: observations with the enantiomers of WB 4101 separated through their amides of N-tosyl-(S)-proline. Chirality. 4:1992;16-20.
2. 1A receptors. J. Med. Chem. 42:1999;4214-4224.
3. 1-adrenoreceptor subtypes. J. Med. Chem. 41:1998;4844-4853.
4. Bylund D.B., Eikenberg D.C., Hieble J.P., Langer S.Z., Lefkowitz R.J., Minneman K.P., Molinoff P.B., Ruffolo R.R. Jr., Trendelenburg U. IV. International union of pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 46:1994;121-136.
5. 2-adrenoreceptors. Eur. J. Pharmacol. 361:1998;1-15.
6. 1-adrenoceptor classification. Eur. J. Pharmacol., Mol. Pharmacol. Sect. 268:1994;141-149.
7. 1-adrenoceptor classification. Br. J. Pharmacol. 121:1997;1127-1135.
8. 1-Adrenoceptor classification: sharpening Occam's razor. Trends Pharmacol. Sci. 15:1994;167-170.
9. Giardinà D., Angeli P., Brasili L., Gulini U., Melchiorre C., Strappaghetti G. Synthesis and α-blocking activity of some cyclic and open analogues of WB 4101. Eur. J. Med. Chem. 19:1984;411-414.
10. 1-adrenoreceptor blocking activity. J. Med. Chem. 32:1989;50-55.
11. 1-antagonist activity of new prazosin- and benextramine-related tetraamine disulfides. Eur. J. Med. Chem. 32:1997;9-20.
12. 1B-adrenoceptor antagonist. Eur. J. Pharmacol. 287:1995;13-16.
13. Giardinà D., Crucianelli M., Marucci G., Melchiorre C., Polidori C., Pompei P., Massi M. Pharmacological evaluation of prazosin- and doxazosin-related compounds with modified piperazine ring. Arzneim.-Forsch./Drug Res. 46(II):1996;1054-1059.
14. 1B-adrenoceptor antagonist. J. Med. Chem. 39:1996;4602-4607.
15. Giardinà D., Gulini U., Massi M., Piloni M.G., Pompei P., Rafaiani G., Melchiorre C. Structure-activity relationships in prazosin-related compounds: 2. Role of the piperazine ring on α-blocking activity. J. Med. Chem. 36:1993;690-698.
16. 1A receptor. J. Med. Chem. 31:1988;1087-1093.
17. 1-adrenoceptors: Consensus update. Pharmacol. Rev. 47:1995;267-270.
18. 2-adrenoceptor subtypes: therapeutic implications. Exp. Opin. Invest. Drugs. 6:1997;367-387.
19. Kenny B., Ballard S., Blagg J., Fox D. Pharmacological options in the treatment of benign prostatic hyperplasia. J. Med. Chem. 40:1997;1293-1315.
20. Leff P. The two-state model of receptor activation. Trends Pharmacol. Sci. 16:1995;89-97.
21. 1-Adrenoceptors: subtype- and organ-selectivity of different agents. In: Giardinà, D., Piergentili, A., Pigini, M. (Eds.), Perspective in Receptor Research. Elsevier, Amsterdam, pp. 135-152.
22. Matyus P., Horvath K. α-Adrenergic approach in the medical management of benign prostatic hyperplasia. Med. Res. Rev. 17:1997;523-535.
23. 1-adrenergic receptor antagonist and renal vasodilator. J. Med. Chem. 28:1985;1142-1145.
24. Melchiorre, C., Belleau, B., 1981. Recent developments in structure-activity relationships among inhibitors of the adrenergic α-receptor. In: Kunos, G. (Ed.), Adrenoceptors and Catecholamine Action, Part A. Wiley, New York, pp. 131-179.
25. 1-adrenoreceptors: neutral or negative antagonism? Il Farmaco. 53:1998;278-286.
26. 1-adrenoreceptors. J. Med. Chem. 27:1984;1535-1536.
27. Melchiorre C., Giardinà D., Gallucci P., Brasili L. Structural requirements for competitive α-adrenoreceptor occupancy by cyclic and open analogues of WB 4101. J. Pharm. Pharmacol. 34:1982;644-683.
28. 1D-adrenoceptor antagonist. Bioorg. Med. Chem. Lett. 8:1998;1353-1358.
29. Nelson W.L., Powell M.L., Dyer D.C. Absolute configuration of glycerol derivatives: 7. Enantiomers of 2-[[[2-(2,6-dimethoxy-phenoxy)ethyl]amino]methyl]-1,4-benzodioxane (WB 4101), a potent competitive α-adrenergic antagonist. J. Med. Chem. 22:1979;1125-1127.
30. Noguera M.A., Ivorra I.D., D'Ocon P. Functional evidence of inverse agonism in vascular smooth muscle. Br. J. Pharmacol. 119:1996;158-164.
31. 1-adrenoreceptor subtypes in the rat vas deferens: binding and functional studies. Br. J. Pharmacol. 107:1992;697-704.
32. 1-adrenoreceptor blocking activity. J. Med. Chem. 31:1988;2300-2304.
33. 1-adrenoreceptor antagonists. J. Med. Chem. 33:1990;2946-2948.
34. 1-adrenoreceptor subtypes. J. Med. Chem. 42:1999;2961-2968.
35. 1A-adrenoreceptor antagonist. J. Med. Chem. 39:1996;2253-2258.
36. Quaglia W., Pigini M., Tayebati S.K., Piergentili A., Giannella M., Marucci G., Melchiorre C. Structure-activity relationships in 1,4-benzodioxan-related compounds: 4. Effect of aryl and alkyl substituents at position 3 on α-adrenoreceptor blocking activity. J. Med. Chem. 36:1993;1520-1528.
37. Ruffolo R.R. Jr., Bondinell W., Hieble J.P. α- and β-Adrenoceptors. From the gene to the clinic: 2. Structure-activity relationships and therapeutic applications. J. Med. Chem. 38:1995;3681-3716.
38. Testa R., Guarneri L., Angelico P., Poggesi E., Taddei C., Sironi G., Colombo D., Sulpizio A.C., Naselsky D.P., Hieble J.P., Leonardi A. Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, Part II. J. Pharmacol. Exp. Ther. 281:1997;1284-1293.